AzTrials
AzTrials

Intraabdominal HypertensionPhase 3GhadaNCT02639013

an Educational Program About Abdominal Compartment Syndrome

A Phase 3 study testing transducer technique in people with Intraabdominal Hypertension, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Early detection of intra-abdominal hypertension is essential to the prevention of abdominal compartment syndrome and requires close surveillance of intra-abdominal hypertension in patients at increased risk. Read more about this study

Who is it for?
Ages 15 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Intraabdominal Hypertension
What is being tested?
transducer technique
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
Dec 2015to Oct 2016
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • all nurses that have more than one years experience in the trauma ,general and gastrointestinal ICU

Who cannot join

  • nurses less than one year experience

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Nursing

    Egypt, Assuit, 02

Other trials in Egypt

About this study

Official title: Temporal Trend Analysis of Nurse's Knowledge and Practice Before and After Implementing an Educational Program Regarding Abdominal Compartment Syndrome

Early detection of intra-abdominal hypertension is essential to the prevention of abdominal compartment syndrome and requires close surveillance of intra-abdominal hypertension in patients at increased risk. intra-abdominal hypertension measurements are often taken by the bedside nurse, and in some cases, initiation of serial intra-abdominal hypertension monitoring is prompted by critical care nurses.

Read the detailed description

Measurement of intra-abdominal pressure is simple, inexpensive, safe and accurate method in determining the presence of intra-abdominal hypertension. This measurement can guide patient management. Monitoring intra-abdominal pressure and abdominal per-fusion pressure.

for signs of abdominal compartment syndrome has become an inexpensive and useful diagnostics tool for identifying complications. An integrated approach to screening and monitoring for intra-abdominal hypertension may improve patient outcomes and decrease hospital costs. Due to the high incidence of intra-abdominal hypertension and abdominal compartment syndrome, it is essential for critical care nurses to regularly monitor intra-abdominal pressure and abdominal per-fusion pressure.

Critical care nurses have the ability to identify intra-abdominal hypertension and abdominal compartment syndrome, implement and evaluate management interventions. Nursing practice should be centered on evidence based practice guidelines . Nurses should provide a standard of care in managing patients who are at risk of intra-abdominal hypertension and abdominal compartment syndrome from pre hospital, emergency, operating room and intensive care areas

Being tested
transducer technique
Medical subject headings
Intra-Abdominal Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transducer techniqueProcedure or surgery

    Also called monitoring intraabdominal pressure

    the nurses will receive the intervention ( the transducer method) to measure intraabdominal pressure intraabdominal hypertension and how to measure intraabdominal pressure in the third section

Study groups in NCT02639013
Study groupRoleWhat they receive
ttransducer techniqueExperimentalthe nurses will measure intraabdominal pressure at each shift during the day by using transducer technique
Receives: Procedure: transducer technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. improve nurses knowledge and practice about abdominal compartment syndrome

    pretest and post questionaire will be used to evaluate the improvement in nurses knowledge and practice about abdominal compartment syndrome

    Measured: 6 months

Secondary outcomes (1)
  1. prevent abdominal compartment syndrome

    measure inta-abdominal pressure correctly and continuously monitor signs of increased intrabdominal pressure

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2015 (estimated)
  2. Study startDec 2015
  3. Primary completionApr 2016 (estimated)
  4. Study completionOct 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02639013
Sponsor's protocol ID
AAH100
Acronym
Ghada
Status last verified
Nov 2015
First submitted
17 Dec 2015
Last updated
24 Dec 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Newcombe J, Mathur M, Bahjri K, Ejike JC. Pediatric critical care nurses' experience with abdominal compartment syndrome. Ann Intensive Care. 2012 Jul 5;2 Suppl 1(Suppl 1):S6. doi: 10.1186/2110-5820-2-S1-S6. Epub 2012 Jul 5.

    PubMed 22873422
  • Hunt L, Frost SA, Hillman K, Newton PJ, Davidson PM. Management of intra-abdominal hypertension and abdominal compartment syndrome: a review. J Trauma Manag Outcomes. 2014 Feb 5;8(1):2. doi: 10.1186/1752-2897-8-2.

    PubMed 24499574

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing transducer technique in people with Intraabdominal Hypertension, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

improve nurses knowledge and practice about abdominal compartment syndrome (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02639013, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in